批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1976/07/21 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/10/17 |
SUPPL-38(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/12/18 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/03/21 |
SUPPL-32(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/02/09 |
SUPPL-31(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/02/17 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/08/18 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/05/29 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2015/01/22 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2014/07/18 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2005/04/26 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/11/27 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 2002/11/27 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC)-Packaging |
PRIORITY
|
|
|
| 2002/11/27 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC)-Formulation |
PRIORITY
|
|
|
| 2002/11/27 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2002/10/29 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1992/12/22 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
| 1988/05/25 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
| 1986/08/25 |
SUPPL-5(补充) |
Approval |
Efficacy-New Indication |
|
|
|
| 1985/07/15 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1979/10/18 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1977/09/14 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 001 |
6803046 |
2022/08/16 |
|
Y |
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
>>>活性成分:SINCALIDE; 剂型/给药途径:POWDER;INTRAVENOUS; 规格:0.005MG/VIAL; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 017697 |
001 |
NDA |
KINEVAC |
SINCALIDE |
POWDER;INTRAVENOUS |
0.005MG/VIAL |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
BRACCO |
| 210850 |
001 |
NDA |
SINCALIDE |
SINCALIDE |
POWDER;INTRAVENOUS |
0.005MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2022/11/22
|
MAIA PHARMS INC |